Skip to content
CED Clinic
Contact Us Book Consultation GLP-1 Care
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
  • Facebook
  • X
  • Email
  • Instagram
  • YouTube
  • Substack
  • Dr Caplan’s Book
CED Clinic CED Clinic CED Clinic

Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.

CED Clinic CED Clinic CED Clinic

Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.

  • 📍 Main Menu
    • Home
    • CED Clinic Heart: Our Values
    • Learn More: CED Clinic
    • Contact us
      • Leave a Message
      • Request Telemedicine Visit
    • Meet Dr. Caplan
      • Dr Caplan on Social Media
      • Dr Caplan's Substack
      • Dr Caplan's Podcast
      • Dr Caplan's Book: Doctor-Approved Cannabis Handbook
    • Meet Erin Caplan, NP
    • Ask Dr Caplan (public Q&A)
    • Discussion Forums
    • SiteMap
  • Patient Care
    • New Patients - Welcome!
      • Book a Virtual Appointment
      • Intake Form
      • How to Get a Medical Marijuana Card (in MA)
      • Qualifying Conditions
      • Ailments That Cannabis Treats
      • Testimonials
      • Patient Stories
      • Adult Cannabis Care
      • Autism, Behavior & Language Help
    • Before & After Apppointments
      • Request a Virtual Visit
      • Your Cannabis Journey
      • Your First Visit
      • Registration Information
      • Caregiver Information
      • After Registration
      • Which Products Are For You?
    • Cannabis & Seniors
      • 💜 Caregiver Support for Seniors
      • Seniors & Healthy Aging
      • Support for Caregiver of Seniors
      • Cannabis & Seniors: A New Chapter in Comfort
      • Cancer & Terminal Illness Support
      • End-of-Life Planning
      • Blog: Rising Cannabis Use in Older Adults
    • Pediatrics & Adolescents
      • Pediatric Care at CED Clinic
      • Pediatrics: Safety, Evidence & Risks
      • Cannabis for Young People: FAQ
      • 5 Benefits of Pediatric Cannabis Certification
      • Learn about Pedi & Adolescent Care
      • 10 Ways Cannabis Supports Children’s Behavior
      • Children & Behavior Support
      • Safe Dosing for Kids
      • Complex Pediatric Care
    • Sponsor a Visit (Give a Gift of Care)
    • Discounts at CED
      • Lottery for a Free Consultation
      • Discounts, Coupons, and Free Consultations
      • Discounts at Dispensaries (MA)
    • GLP-1 Weight Management
    • Health Quiz: Are You Healthy?
  • Education
    • Practical Tips + Guidance
      • Travel With Cannabis
      • COA Guide & Lab Safety
      • Fixing Your Cannabis Tolerance
      • Why Cannabis Works
      • Smart Cannabis Dosing: Sweet Spot?
      • Cannabis Myths + Blind Spots
      • How to Talk to Your Doc about Cannabis
      • Slow Medicine: How Cannabis Heals Over Time
      • Why The War on Pot Rages
      • Feeling Too High?
      • Cannabis & Mental Health Truths
      • Cannabis Cough: The Basics
      • Science of The Cannabis Cough
      • What To Do: Feeling Too Racy
      • Weed Anxiety Explained: Paranoia, Panic & Relief
      • Why Aren’t Edibles Don't Work for You?
      • When to Pause
      • Cannabis Hyperemesis Syndrome (CHS): What to Know
    • Health & Wellness
      • Cannabis & Health (general)
      • Choosing Cannabis
      • Tips for Maximizing Effectiveness
      • Cannabis & Metabolism: Be Amazed!
      • Cannabis for Sleep
      • Cannabis for Stress
      • Cannabis for Pain
      • Topicals Guide
      • Future of Cannabis
    • Learn by Illness or Condition
      • Custom Cannabis Protocol
      • Mental Health & Neurological Disorders
      • ADHD: A Guide to Focus, Calm, and Control
      • Crohn’s and Gut Health: Relief Strategies
      • Gastrointestinal & Autoimmune Conditions
      • Dermatological & Skin Conditions
      • Chronic Pain & Inflammation
      • Women’s Health & Hormonal Conditions
      • Pregnancy & Cannabis, Explained
      • Sleep Disorders & Circadian Rhythm Issues
      • Pain Management with Cannabis
      • Autism & Behavior: Expert Guidance for Families
      • Post-Surgical & Injury Recovery
      • Substance Dependence & Withdrawal Support
    • Learn about Products
      • Types of Cannabis Sold
      • CBD Strength Guide
      • Cannabis Tolerance: Management
      • Topical Cannabis Products: Guide to Uses, Benefits & DIY
      • Unique Cannabinoids: Beyond THC & CBD
      • Vaporizing Cannabis: Safer, Effective Consumption
    • Best Ways To Take Cannabis
      • Cannabis FAQs (basic)
      • Start Here
      • Cannabis Therapy Guidance
      • Dosage & Usage Guide
      • Nebulized Cannabis Guide
      • Topicals & Lotions
      • Tinctures & Oils
      • Cannabis Edibles & Capsules
      • Inhalables & Vaporization
    • Educational Resources
      • Dr Caplan's Book Website
        • Personalized, Signed Copy
        • My Book (Amazon)
        • Each Book Dedication is Unique!
      • FAQ Encyclopedia
      • Dr Caplan's Classroom
        • Book Diagrams + CaplanCannabis Site (free)
        • Video Library
        • Handouts & Guides
        • AI Book Review
        • Spotify: Green Table Talk Podcast
        • YouTube
        • Dr Caplan's Book (Order Now - Amazon!)
      • Cannabis Basics Overview
      • The Problems Cannabis Helps Us Manage
      • Endocannabinoid System
      • Cannabis Science
      • CED Cannabis Literature Library
      • Patient Care & Findings
      • Patient Insights
    • Guide: How to Buy Cannabis Flower
    • FAQ (Cannabis Encyclopedia)
    • Popular Blogs: 2026
      • Long-Term Effects of Cannabis
      • Reset Your Cannabis Tolerance
      • Weed Anxiety Explained: A Doctor’s Guide to Paranoia, Panic & Relief
      • 5 Reasons CBD CBG Topicals For Eczema Care is Amazing
      • Cannabis for Sleep
      • Slow Medicine: How Cannabis Heals Over Time
      • Why Aren’t Edibles Working for You?
      • When Cannabis Might NOT Be Right for You
      • Women’s Health & Hormonal Conditions
      • Cannabis for Stress
      • Cannabis for ADHD: A Guide to Focus, Calm, and Control
      • Too High? What To Do
      • Moldy Marijuana: MA recalls moldy flower
    • CED Favorites
      • Video: Cannabis Tolerance Explained
      • Plant Nurition Explained
      • Light THC & CBD Picks
      • High-Potency Cannabis Guide
      • Sugar-Free Cannabis Options
      • Cannabis & Your Heart
      • Cannabis and Psychosis
      • Vaginal Suppositories Page
      • Rectal Suppositories Page
      • Medical Cannabis Crossroads
      • Cannabis and Heart Health
      • Is Weed Addictive? Dependence vs Addiction
      • Cannabis and Menopause
      • Cannabis & Aging
      • CBD & Liver Enzymes
      • How Cannabis Works Differently
      • Emergence: How Wholes Outthink Parts
      • Our New Post-Covid Baseline
    • Non-Cannabis Writing
      • Social Capacity vs Identity: Connection
      • AI in Medicine Explained
      • Tylenol & Autism Debate
      • Power of Clicks and Likes
      • Rethinking Diagnosis in Kids
  • Partner with Dr Caplan
    • Partner on Education & Research
    • Work with Dr Caplan
    • Media Inquiries
    • Interview Dr. Caplan
    • Book Dr. Caplan to Speak
    • Clinical Cannabis Education Program
    • Modular (Custom) Professional Education
    • Volunteer at CED (Social Impact Work)
    • Cannabis Business Consulting
    • Building Big Data
    • Promote With CED Clinic
  • Resources, Supplies, Events
    • Share YOUR Story
    • Trusted Resources & Products
    • Shop Products: Gummies, Drinks, Oils, Flower...
    • Handmade Glass
    • Myriams CBD
    • Outside Resources
    • Past Events
    • Dispensary Highlights
    • Fireside Chats
  • 📍 Main Menu
    • Home
    • CED Clinic Heart: Our Values
    • Learn More: CED Clinic
    • Contact us
      • Leave a Message
      • Request Telemedicine Visit
    • Meet Dr. Caplan
      • Dr Caplan on Social Media
      • Dr Caplan's Substack
      • Dr Caplan's Podcast
      • Dr Caplan's Book: Doctor-Approved Cannabis Handbook
    • Meet Erin Caplan, NP
    • Ask Dr Caplan (public Q&A)
    • Discussion Forums
    • SiteMap
  • Patient Care
    • New Patients - Welcome!
      • Book a Virtual Appointment
      • Intake Form
      • How to Get a Medical Marijuana Card (in MA)
      • Qualifying Conditions
      • Ailments That Cannabis Treats
      • Testimonials
      • Patient Stories
      • Adult Cannabis Care
      • Autism, Behavior & Language Help
    • Before & After Apppointments
      • Request a Virtual Visit
      • Your Cannabis Journey
      • Your First Visit
      • Registration Information
      • Caregiver Information
      • After Registration
      • Which Products Are For You?
    • Cannabis & Seniors
      • 💜 Caregiver Support for Seniors
      • Seniors & Healthy Aging
      • Support for Caregiver of Seniors
      • Cannabis & Seniors: A New Chapter in Comfort
      • Cancer & Terminal Illness Support
      • End-of-Life Planning
      • Blog: Rising Cannabis Use in Older Adults
    • Pediatrics & Adolescents
      • Pediatric Care at CED Clinic
      • Pediatrics: Safety, Evidence & Risks
      • Cannabis for Young People: FAQ
      • 5 Benefits of Pediatric Cannabis Certification
      • Learn about Pedi & Adolescent Care
      • 10 Ways Cannabis Supports Children’s Behavior
      • Children & Behavior Support
      • Safe Dosing for Kids
      • Complex Pediatric Care
    • Sponsor a Visit (Give a Gift of Care)
    • Discounts at CED
      • Lottery for a Free Consultation
      • Discounts, Coupons, and Free Consultations
      • Discounts at Dispensaries (MA)
    • GLP-1 Weight Management
    • Health Quiz: Are You Healthy?
  • Education
    • Practical Tips + Guidance
      • Travel With Cannabis
      • COA Guide & Lab Safety
      • Fixing Your Cannabis Tolerance
      • Why Cannabis Works
      • Smart Cannabis Dosing: Sweet Spot?
      • Cannabis Myths + Blind Spots
      • How to Talk to Your Doc about Cannabis
      • Slow Medicine: How Cannabis Heals Over Time
      • Why The War on Pot Rages
      • Feeling Too High?
      • Cannabis & Mental Health Truths
      • Cannabis Cough: The Basics
      • Science of The Cannabis Cough
      • What To Do: Feeling Too Racy
      • Weed Anxiety Explained: Paranoia, Panic & Relief
      • Why Aren’t Edibles Don't Work for You?
      • When to Pause
      • Cannabis Hyperemesis Syndrome (CHS): What to Know
    • Health & Wellness
      • Cannabis & Health (general)
      • Choosing Cannabis
      • Tips for Maximizing Effectiveness
      • Cannabis & Metabolism: Be Amazed!
      • Cannabis for Sleep
      • Cannabis for Stress
      • Cannabis for Pain
      • Topicals Guide
      • Future of Cannabis
    • Learn by Illness or Condition
      • Custom Cannabis Protocol
      • Mental Health & Neurological Disorders
      • ADHD: A Guide to Focus, Calm, and Control
      • Crohn’s and Gut Health: Relief Strategies
      • Gastrointestinal & Autoimmune Conditions
      • Dermatological & Skin Conditions
      • Chronic Pain & Inflammation
      • Women’s Health & Hormonal Conditions
      • Pregnancy & Cannabis, Explained
      • Sleep Disorders & Circadian Rhythm Issues
      • Pain Management with Cannabis
      • Autism & Behavior: Expert Guidance for Families
      • Post-Surgical & Injury Recovery
      • Substance Dependence & Withdrawal Support
    • Learn about Products
      • Types of Cannabis Sold
      • CBD Strength Guide
      • Cannabis Tolerance: Management
      • Topical Cannabis Products: Guide to Uses, Benefits & DIY
      • Unique Cannabinoids: Beyond THC & CBD
      • Vaporizing Cannabis: Safer, Effective Consumption
    • Best Ways To Take Cannabis
      • Cannabis FAQs (basic)
      • Start Here
      • Cannabis Therapy Guidance
      • Dosage & Usage Guide
      • Nebulized Cannabis Guide
      • Topicals & Lotions
      • Tinctures & Oils
      • Cannabis Edibles & Capsules
      • Inhalables & Vaporization
    • Educational Resources
      • Dr Caplan's Book Website
        • Personalized, Signed Copy
        • My Book (Amazon)
        • Each Book Dedication is Unique!
      • FAQ Encyclopedia
      • Dr Caplan's Classroom
        • Book Diagrams + CaplanCannabis Site (free)
        • Video Library
        • Handouts & Guides
        • AI Book Review
        • Spotify: Green Table Talk Podcast
        • YouTube
        • Dr Caplan's Book (Order Now - Amazon!)
      • Cannabis Basics Overview
      • The Problems Cannabis Helps Us Manage
      • Endocannabinoid System
      • Cannabis Science
      • CED Cannabis Literature Library
      • Patient Care & Findings
      • Patient Insights
    • Guide: How to Buy Cannabis Flower
    • FAQ (Cannabis Encyclopedia)
    • Popular Blogs: 2026
      • Long-Term Effects of Cannabis
      • Reset Your Cannabis Tolerance
      • Weed Anxiety Explained: A Doctor’s Guide to Paranoia, Panic & Relief
      • 5 Reasons CBD CBG Topicals For Eczema Care is Amazing
      • Cannabis for Sleep
      • Slow Medicine: How Cannabis Heals Over Time
      • Why Aren’t Edibles Working for You?
      • When Cannabis Might NOT Be Right for You
      • Women’s Health & Hormonal Conditions
      • Cannabis for Stress
      • Cannabis for ADHD: A Guide to Focus, Calm, and Control
      • Too High? What To Do
      • Moldy Marijuana: MA recalls moldy flower
    • CED Favorites
      • Video: Cannabis Tolerance Explained
      • Plant Nurition Explained
      • Light THC & CBD Picks
      • High-Potency Cannabis Guide
      • Sugar-Free Cannabis Options
      • Cannabis & Your Heart
      • Cannabis and Psychosis
      • Vaginal Suppositories Page
      • Rectal Suppositories Page
      • Medical Cannabis Crossroads
      • Cannabis and Heart Health
      • Is Weed Addictive? Dependence vs Addiction
      • Cannabis and Menopause
      • Cannabis & Aging
      • CBD & Liver Enzymes
      • How Cannabis Works Differently
      • Emergence: How Wholes Outthink Parts
      • Our New Post-Covid Baseline
    • Non-Cannabis Writing
      • Social Capacity vs Identity: Connection
      • AI in Medicine Explained
      • Tylenol & Autism Debate
      • Power of Clicks and Likes
      • Rethinking Diagnosis in Kids
  • Partner with Dr Caplan
    • Partner on Education & Research
    • Work with Dr Caplan
    • Media Inquiries
    • Interview Dr. Caplan
    • Book Dr. Caplan to Speak
    • Clinical Cannabis Education Program
    • Modular (Custom) Professional Education
    • Volunteer at CED (Social Impact Work)
    • Cannabis Business Consulting
    • Building Big Data
    • Promote With CED Clinic
  • Resources, Supplies, Events
    • Share YOUR Story
    • Trusted Resources & Products
    • Shop Products: Gummies, Drinks, Oils, Flower...
    • Handmade Glass
    • Myriams CBD
    • Outside Resources
    • Past Events
    • Dispensary Highlights
    • Fireside Chats
Subscribe
Close

Search

Exclusive
Semaglutide Cognition Psychiatric Cohort Study
August 21, 2026
Semaglutide and Cognition in Psychiatric Care: What a 13,007-Patient Cohort Found
New Mexico welcome sign under a blue sky, representing a statewide cannabis regulation transition
August 21, 2026
New Mexico Cannabis Tracking Switch: What Patients Should Know
cannabis carrot harissa spread finished recipe styled as the emotional anchor with warm editorial food photography
August 21, 2026
Cannabis Carrot Harissa Spread Recipe
Drinking down to record low, but cannabis use might be 'trading one problem for another'
August 21, 2026
Drinking down to record low, but cannabis use might be ‘trading one problem for another’
Medical cannabis: 4 specialties lead prescriptions
August 21, 2026
Medical cannabis: 4 specialties lead prescriptions
A Look at More Than 30 Cannabis and Cannabinoid Clinical Trials Published in 2026
August 21, 2026
A Look at More Than 30 Cannabis and Cannabinoid Clinical Trials Published in 2026
Canada invests $24 million in consortium to study cannabis and brain health
August 21, 2026
Canada invests $24 million in consortium to study cannabis and brain health
Cannabinoids may have benefits for insomnia - Study Summary - Examine.com
August 21, 2026
Cannabinoids may have benefits for insomnia – Study Summary – Examine.com
GLP-1 Idiopathic Intracranial Hypertension | Evidence Report
August 20, 2026
GLP-1 Drugs and Intracranial Hypertension: What a Low-Certainty Meta-Analysis Found
cannabis blueberry baked oatmeal cups finished recipe styled as the emotional anchor with warm editorial food photography
August 20, 2026
Cannabis Blueberry Baked Oatmeal Cups Recipe
Real-Time Monitoring of Youth Substance Use: A New Preprint Review | ecological momentary assessment substance use
August 20, 2026
Real-Time Monitoring of Youth Substance Use: What a New Preprint Review of 43 Studies Found
Brain region-specific and sex-dependent roles of 2-arachidonoylglycerol in the retrieval of ...
August 20, 2026
Brain region-specific and sex-dependent roles of 2-arachidonoylglycerol in the retrieval of …
Cannabis use disorder rising among US adults, study finds - NBC 15
August 20, 2026
Cannabis use disorder rising among US adults, study finds – NBC 15
Cannabis use disorder rising among US adults, study finds
August 20, 2026
Cannabis use disorder rising among US adults, study finds
Marijuana's menace: cannabis use disorder spiking, study says
August 20, 2026
Marijuana’s menace: cannabis use disorder spiking, study says
A Look at More Than 30 Cannabis and Cannabinoid Clinical Trials Published in 2026
August 20, 2026
A Look at More Than 30 Cannabis and Cannabinoid Clinical Trials Published in 2026
cannabis peach oat crumble finished recipe styled as the emotional anchor with warm editorial food photography
August 20, 2026
Cannabis Peach Oat Crumble Recipe
Canada's New Cannabis Brain Health Research Consortium
August 20, 2026
Canada’s New Cannabis Brain Health Research Consortium
Government of Canada investing $24 million to establish cannabis and brain health ...
August 20, 2026
Government of Canada investing $24 million to establish cannabis and brain health …
Healing without the High: Elizabeth Mack, RN on the Power of Cannabino - Dr. Clark Store
August 20, 2026
Healing without the High: Elizabeth Mack, RN on the Power of Cannabino – Dr. Clark Store
Medicinal cannabis prescriptions surge to more than 72,000 in a year
August 20, 2026
Medicinal cannabis prescriptions surge to more than 72,000 in a year
PleoPharma Awarded $6.5 Million NIDA Grant to Support Phase 3 Trial of PP-01 for ...
August 20, 2026
PleoPharma Awarded $6.5 Million NIDA Grant to Support Phase 3 Trial of PP-01 for …
GLP-1 SGLT2 Combination Cardiorenal Outcomes | Evidence Report
August 20, 2026
GLP-1 Plus SGLT2 Therapy: What an Exploratory Cardiorenal Meta-Analysis Found
Neutral laboratory glassware representing cannabinoid product testing
August 20, 2026
Ireland Finds High-Risk Synthetic Cannabinoids in CBD and Cannabis Products
Dulaglutide vs Insulin in Thalassaemia Diabetes Trial | dulaglutide thalassaemia diabetes trial
August 20, 2026
Dulaglutide vs Insulin in Adolescents With Thalassaemia-Related Diabetes
What are the health risks from synthetic cannabinoids?
August 20, 2026
What are the health risks from synthetic cannabinoids?
Virginia family fears new hemp law will cut off daughter's longtime seizure treatment
August 20, 2026
Virginia family fears new hemp law will cut off daughter’s longtime seizure treatment
Study Finds CBD Improves Social Deficits, Hyperactivity and Repetitive Behaviors in Autism Model
August 20, 2026
Study Finds CBD Improves Social Deficits, Hyperactivity and Repetitive Behaviors in Autism Model
Does Cannabis Lower Blood Sugar *Nkzlj1NKw*
August 20, 2026
Does Cannabis Lower Blood Sugar *Nkzlj1NKw*
Cannabinoids in Sleep and Sleep Disorders: S9-Ep1
August 20, 2026
Cannabinoids in Sleep and Sleep Disorders: S9-Ep1
Daily Cannabis News Brief for 8/18/2026
August 19, 2026
Daily Cannabis News Brief for 8/18/2026
Home/GLP-1 Care/GLP-1 Receptor Agonists: Diabetes Risk Despite Weight Loss
ced pexels 7653346
GLP-1 Care

GLP-1 Receptor Agonists: Diabetes Risk Despite Weight Loss

By CEDclinic_admin
7 Min Read
Comments Off on GLP-1 Receptor Agonists: Diabetes Risk Despite Weight Loss
GLP-1 Clinical Relevance  #51Moderate Clinical Relevance  Relevant context for GLP-1 prescribers; interpret with care.
⚕ GLP-1 News  |  CED Clinic
Clinical ResearchObservational StudyType 2 Diabetes PreventionGLP-1 Receptor AgonistEndocrinologyAdults with ObesityGlycemic ControlInsulin ResistanceTULIP StudyMetabolic Health AssessmentWeight Loss ParadoxGlucose Deterioration Risk
Why This Matters
Family medicine clinicians prescribing GLP-1 receptor agonists must recognize that weight loss alone does not guarantee improved glycemic control or resolution of insulin resistance in all patients, as demonstrated by the TULIP cohort showing glucose deterioration in a subset despite weight reduction. This finding necessitates continued metabolic monitoring including fasting glucose, HbA1c, and insulin levels independent of weight loss trajectories to identify treatment failures early and adjust therapeutic strategy accordingly. Understanding this metabolic heterogeneity prevents false reassurance from weight reduction metrics and ensures clinically appropriate escalation or combination therapy in patients whose underlying insulin resistance persists.
Clinical Summary

The TULIP study enrolled 190 patients to evaluate metabolic outcomes beyond weight reduction alone. A subset of study participants demonstrated persistent insulin resistance despite achieving weight loss, which correlated with deterioration in blood glucose levels during follow-up. This finding demonstrates that weight loss as a standalone marker does not necessarily reflect improvement in underlying glucose metabolism or insulin sensitivity in all patients.

The clinical implications for prescribers center on the heterogeneity of metabolic response to interventions. Some patients experience metabolic decoupling, where weight reduction occurs without concordant improvement in insulin resistance or fasting glucose levels. This population may progress toward or experience frank hyperglycemia despite meeting weight loss targets, indicating that weight alone should not serve as the primary efficacy endpoint when evaluating diabetes prevention or metabolic health interventions.

For clinical practice, these findings support the value of monitoring insulin resistance markers and glucose parameters independently from weight metrics. Patients achieving weight loss but demonstrating persistent insulin resistance or worsening glucose control may warrant treatment intensification, additional pharmacologic intervention, or assessment of adherence and lifestyle factors. The data suggest that a subset of patients requires more aggressive metabolic management than weight loss alone provides, with direct measurement of insulin sensitivity and glycemic control essential to identifying those at continued diabetes risk.

Clinical Takeaway
Patients taking GLP-1 medications may achieve significant weight loss while still developing worsening glucose control if underlying insulin resistance remains unaddressed. The TULIP study demonstrates that weight reduction alone does not guarantee metabolic improvement in all patients, particularly those with persistent insulin resistance. This finding suggests the need for comprehensive metabolic assessment beyond weight outcomes, including regular glucose monitoring and insulin sensitivity markers. In clinical practice, counsel patients that GLP-1 therapy requires concurrent lifestyle optimization and metabolic monitoring to prevent diabetes progression despite apparent weight loss success.
Dr. Caplan’s Take
“What the TULIP study demonstrates is something I see regularly in clinical practice: weight loss alone doesn’t guarantee metabolic recovery in every patient, and we can have individuals who lose significant weight yet continue to worsen their glucose control due to persistent underlying insulin resistance. This finding fundamentally changes how I counsel patients, because I now emphasize that we’re not just treating a number on the scale-we’re treating insulin resistance and beta cell dysfunction, which may require more aggressive pharmacotherapy even when weight loss is occurring. The practical implication for my practice is straightforward: I monitor HbA1c and fasting glucose closely in patients on GLP-1 therapy regardless of their weight loss trajectory, because metabolic improvement must be independently confirmed rather than assumed. For patients, this means the conversation shifts from ‘you need to lose X pounds’ to ‘we need to restore your metabolic health,’ which actually improves adherence and reduces shame.”
Clinical Perspective
🧠 The TULIP study’s identification of patients with persistent insulin resistance despite weight loss on GLP-1 therapy represents a critical refinement to our understanding of metabolic heterogeneity in this population, challenging the assumption that weight reduction alone predicts glycemic outcomes. This finding underscores that GLP-1 receptor agonists, while potent weight loss agents, do not uniformly improve insulin sensitivity across all patient phenotypes, particularly in those with baseline severe insulin resistance or metabolic dysfunction-associated fatty liver disease. Clinicians should implement baseline fasting insulin and HOMA-IR assessment in all patients initiating GLP-1 therapy to risk-stratify for progression to diabetes despite weight loss, enabling earlier consideration of dual or triple therapy approaches such as adding SGLT2 inhibitors or thiazolidinediones for patients demonstrating inadequate metabolic improvement at 12 weeks.

💬 Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →

Have thoughts on this? Share it:

𝕏 Share on Xin Share on LinkedIn🦥 Share on BlueSky📷 Follow on Instagram📝 Read more on Substack🔔 Subscribe via RSS
📰 Source: Google Alert – (“weight loss results” OR “rapid weight loss” OR “appetite suppression” OR “fat loss” OR “metabolic health” OR “insulin resistance”)
CED Clinic logo
Nationwide GLP-1 Care
Looking for thoughtful, physician-led GLP-1 guidance?
CED Clinic offers GLP-1 and metabolic guidance across the United States, including evaluation, prescribing support, side-effect management, and longer-term follow-up for people seeking careful, personalized care.
Learn More Book Now
Physician-led GLP-1 metabolic care available nationwide through CED Clinic

Table of Contents

    • FAQ
        • Can I stop worrying about diabetes if I lose weight on GLP-1 medication?
        • What is insulin resistance and why does it matter if I’m taking GLP-1?
        • Will GLP-1 medication fix my insulin resistance?
        • Why did some patients in the TULIP study get worse blood sugar despite weight loss?
        • How often should my doctor check my blood sugar while I am on GLP-1?
        • Is there a blood test that shows if I have insulin resistance?
        • If I develop high blood sugar while on GLP-1, does that mean the medication failed?
        • Can I prevent diabetes if I have insulin resistance while taking GLP-1?
        • What does metabolic health mean, and is it different from just losing weight?
        • Should I get genetic testing if I am on GLP-1 and worried about diabetes risk?
  • Newsletter Signup Form
      • Read next
      • Related

FAQ

Can I stop worrying about diabetes if I lose weight on GLP-1 medication?

Weight loss is important, but the TULIP study shows that some patients can lose weight and still develop diabetes because of ongoing insulin resistance. Your doctor needs to monitor your blood sugar and insulin levels regularly, not just the number on the scale.

What is insulin resistance and why does it matter if I’m taking GLP-1?

Insulin resistance means your body does not respond well to the hormone insulin, which controls blood sugar. Even if you lose weight on GLP-1, if you still have insulin resistance, your blood sugar can get worse over time.

Will GLP-1 medication fix my insulin resistance?

GLP-1 medications help with weight loss and can improve blood sugar control, but they do not directly treat all cases of insulin resistance. Your doctor may recommend additional treatments like metformin or lifestyle changes to address insulin resistance.

Why did some patients in the TULIP study get worse blood sugar despite weight loss?

The study found that weight loss alone does not guarantee improvement in how your body handles blood sugar. Insulin resistance can continue underneath weight loss, which is why blood sugar monitoring is critical.

How often should my doctor check my blood sugar while I am on GLP-1?

You should have blood sugar and insulin tests regularly, typically at baseline and then every 3 to 6 months depending on your risk factors. Your doctor will determine the right schedule based on your individual health status.

Is there a blood test that shows if I have insulin resistance?

Yes, your doctor can check fasting insulin levels, glucose levels, and calculate a score called HOMA-IR to measure insulin resistance. These tests help identify whether your insulin resistance is improving even if your weight loss looks good.

If I develop high blood sugar while on GLP-1, does that mean the medication failed?

Not necessarily, as some patients can lose weight but still experience worsening blood sugar due to underlying insulin resistance. This finding shows why comprehensive metabolic monitoring matters more than weight alone.

Can I prevent diabetes if I have insulin resistance while taking GLP-1?

Yes, GLP-1 combined with other treatments like metformin, healthy eating, and exercise can help prevent or delay diabetes. Regular monitoring allows your doctor to catch problems early and adjust your treatment plan.

What does metabolic health mean, and is it different from just losing weight?

Metabolic health includes how well your body handles blood sugar, insulin, cholesterol, and blood pressure overall. Weight loss is one part of metabolic health, but you need all these markers to be healthy to truly prevent disease.

Should I get genetic testing if I am on GLP-1 and worried about diabetes risk?

Genetic testing is not routinely needed, but your doctor may recommend it based on your family history and current metabolic markers. Standard blood tests for blood sugar and insulin resistance are the primary tools used to assess your diabetes risk.

CED Clinic logo
Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.
Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance
Leave a Message Metabolic Care Medical Consulting Cannabis Care
Dr. Benjamin Caplan
RELATED READING AT CED CLINIC
Continue exploring the evidence
GLP-1 Receptor Agonist Weight Loss: Can Genes Predict Results?

Explore how genetics may influence weight loss outcomes with GLP-1 receptor agonists and implications for personalized treatment.

Learn More
GLP-1 Receptor Agonist Clinical Evidence: Liraglutide vs Semaglutide

Compare clinical evidence on liraglutide and semaglutide for weight loss and metabolic effects in diabetes management.

Read Comparison
GLP-1 Agonist Clinical Evidence: Weight Loss Outcomes

Review clinical outcomes of GLP-1 agonists focusing on weight loss and metabolic health improvements.

Explore Findings
  • Newsletter Signup Form

    Talk to Dr. Caplan

    Dealing with a health concern? We've seen this before.

    30,000+ patients treated. Appointments in Massachusetts and via telemedicine.

    Book a consultation →GLP-1 + cannabis program
    BC

    Dr. Benjamin Caplan, MD

    Board-certified Family Medicine

    20+ years in cannabis medicine. CMO, CED Clinic. Author, Penguin Random House. Principal Investigator in multiple studies.

    Full bio →

    Related reading

    • Conditions A–Z →
    • Cannabis & anxiety →
    • Cannabis & sleep →
    • Cannabinoid profiles →

    Wherever you are

    Dr. Caplan offers consultations for complex conditions and wellness needs. Patients from across the US and internationally are welcome.

    Book a consultation →
    Enter your email address to subscribe to our newsletter.
  • Should be Empty:

Read next

Comparing Tirzepatide and Semaglutide for Weight Loss

Related

Tags:

Adults with ObesityEndocrinologyGLP-1 Receptor AgonistGlucose Deterioration RiskGlycemic ControlInsulin ResistanceMetabolic Health Assessmentobservational studyTULIP StudyType 2 Diabetes PreventionWeight Loss Paradox
Author

CEDclinic_admin

Follow Me
Other Articles
ced pexels 16051945
Previous

GLP-1 Receptor Agonist Safety: Clinical Evidence & FDA Oversight

ced pexels 6823681
Next

Insights on GLP-1 Receptor Agonist Roche Incretin Trial in Type 1 Diabetes

Book Now Intake Form
Dr. Benjamin Caplan, MD Learn About Dr. Caplan
Copyright 2026 — CED Clinic. All rights reserved.

Questions about this condition?

Talk to Dr. Caplan →
CED Clinic
CED Clinic Home
Explore
Cannabis Science
Research & Clinical
Cannabis News
Policy, Humor & News
Metabolic Health
GLP-1 Care & Science
Cannabis Recipes
Infused Foods & Drinks
Book an Appointment Contact CED Clinic
Recent Posts
Loading…
MENU